Methyl-Substituted Conformationally Constrained Rexinoid Agonists for the Retinoid X Receptors Demonstrate Improved Efficacy for Cancer Therapy and Prevention

Por Desphande, Anil, Xia, Gang, Boerma, LeeAnn J., Vines, Kimberly K, Atigadda, Venkatram R., Lobo-Ruppert, Susan, Grubbs, Clinton J., Moeinpour, Fariba L, Smith, Craig D., Christov, Konstantin, Brouillette, Wayne J., Muccio, Donald D.
Publicado no Bioorg Med Chem (2013)